Follow
Tetsuya Nishimoto
Tetsuya Nishimoto
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients
A Asahi, T Nishimoto, Y Okazaki, H Suzuki, T Masaoka, Y Kawakami, ...
The Journal of clinical investigation 118 (8), 2939-2949, 2008
1762008
CD4+ CD25+ Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia
T Nishimoto, M Kuwana
Seminars in hematology 50, S43-S49, 2013
1392013
Critical role of CD4+ CD25+ regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia
T Nishimoto, T Satoh, T Takeuchi, Y Ikeda, M Kuwana
Experimental hematology 40 (4), 279-289, 2012
852012
PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population
C Terao, K Ohmura, Y Kawaguchi, T Nishimoto, A Kawasaki, K Takehara, ...
Arthritis & Rheumatism 65 (2), 472-480, 2013
732013
Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis
XX Nguyen, T Nishimoto, T Takihara, L Mlakar, AD Bradshaw, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 320 (1 …, 2021
392021
Induction of immune tolerance to platelet antigen by short-term thrombopoietin treatment in a mouse model of immune thrombocytopenia
T Nishimoto, M Numajiri, H Nakazaki, Y Okazaki, M Kuwana
International journal of hematology 100, 341-344, 2014
342014
Predominant autoantibody response to GPIb/IX in a regulatory T‐cell‐deficient mouse model for immune thrombocytopenia
T Nishimoto, T Satoh, EK Simpson, H Ni, M Kuwana
Journal of Thrombosis and Haemostasis 11 (2), 369-372, 2013
312013
An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model
T Nishimoto, L Mlakar, T Takihara, C Feghali-Bostwick
International immunopharmacology 28 (2), 1102-1105, 2015
282015
Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis
T Watanabe, T Nishimoto, L Mlakar, J Heywood, M Malaab, S Hoffman, ...
PLoS One 12 (6), e0179917, 2017
242017
A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis
T Nishimoto, N Seta, R Anan, T Yamamoto, Y Kaneko, T Takeuchi, ...
Clin Exp Rheumatol 32 (2), 211-7, 2014
242014
IGFBP-5 promotes fibrosis independently of its translocation to the nucleus and its interaction with nucleolin and IGF
Y Su, T Nishimoto, C Feghali-Bostwick
PLoS One 10 (6), e0130546, 2015
222015
Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia
T Satoh, K Miyazaki, A Shimohira, N Amano, Y Okazaki, T Nishimoto, ...
Blood, The Journal of the American Society of Hematology 122 (11), 1991-1992, 2013
222013
A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus
H Hanaoka, T Nishimoto, Y Okazaki, T Takeuchi, M Kuwana
Arthritis Research & Therapy 22, 1-13, 2020
182020
Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis
S Suzuki, T Nishimoto, M Kohno, K Utsugisawa, Y Nagane, M Kuwana, ...
Journal of Neuroimmunology 258 (1-2), 61-66, 2013
182013
Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4
YY Su, T Nishimoto, S Hoffman, XX Nguyen, JM Pilewski, ...
FASEB bioAdvances 1 (3), 167, 2019
162019
E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
S Sharma, T Watanabe, T Nishimoto, T Takihara, L Mlakar, XX Nguyen, ...
JCI insight 6 (24), 2021
132021
Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors
T Nishimoto, Y Okazaki, M Numajiri, M Kuwana
International journal of hematology 105, 598-605, 2017
42017
Ameliorating fibrosis in murine and human tissues with END55, an Endostatin-derived fusion protein made in plants
L Mlakar, SM Garrett, T Watanabe, M Sanderson, T Nishimoto, J Heywood, ...
Biomedicines 10 (11), 2861, 2022
32022
Lysyl oxidase induces fibrosis via upregulation of IL-6 and serves as a biomarker to monitor response to therapy
T Nishimoto, T Takihara, L Mlakar, J Heywood, A Bradshaw, ...
A74. MATRIX: DRIVERS AND TARGETS, A2441-A2441, 2016
32016
Anti-Fibrotic Mechanisms of Endostatin-Derived Peptide Are the Result of Reduction in Pro-Fibrotic Mediators and Promotion of Extracellular Matrix Degradation
T Watanabe, T Nishimoto, T Takihara, L Mlakar, Y Su, ...
Arthritis & Rheumatology 69, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20